Header Logo

Connection

ROBERTO MIRANDA to Immunoconjugates

Back to Details
This is a "connection" page, showing publications ROBERTO MIRANDA has written about Immunoconjugates.
ROBERTO MIRANDA
Connection Strength
0.106
Immunoconjugates
  1. Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding. J Cutan Pathol. 2016 Dec; 43(12):1161-1166.
    View in: PubMed
    Score: 0.106
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.